Showing results (2461-2470 of 4,229) with videos related to

Sort By:
Pageof 423
Discover Oncology|August 29, 2023
OSR1 downregulation indicates an unfavorable prognosis and activates the NF-κB pathway in ovarian cancerZhong Yu, Ling Ouyang
Discover Oncology|August 29, 2023
Effects of metalloprotease ADAMTS12 on cervical cancer cell phenotype and its potential mechanismRuanmin Zou, Ruihong Gu, Xinyu Tu, et al.
Discover Oncology|October 10, 2023
Exploring oncogenes for renal clear cell carcinoma based on G protein-coupled receptor-associated genesChengcun Zhu, Zhou Sun, Jie Wang, et al.
Discover Oncology|September 23, 2023
Impact of primary resistance to front-line targeted therapy in metastatic renal cell carcinoma on subsequent immune-checkpoint-inhibitionJ H Börner, S Neuberger, E Juengel, et al.
Discover Oncology|September 23, 2023
Role of exosome-mediated molecules SNORD91A and SLC40A1 in M2 macrophage polarization and prognosis of ESCCYang Xue, Zhengyan Cheng, Yida Liao, et al.
Discover Oncology|September 22, 2023
TRIP13 overexpression in hepatocellular carcinoma: implications for poor prognosis and immune cell infiltrationJiapeng Xue, Hongfen Wu, Yun Shi, et al.
Discover Oncology|July 18, 2023
RIPK1 is aberrantly expressed in multiple B-cell cancers and implicated in the underlying pathogenesisBaoyu Wu, Jingyu Li, Han Wang, et al.
Discover Oncology|July 19, 2023
Evolving therapeutic landscape of diffuse large B-cell lymphoma: challenges and aspirationsJason Yongsheng Chan, Nagavalli Somasundaram, Nicholas Grigoropoulos, et al.
Discover Oncology|July 13, 2023
Emerging roles of noncoding RNAs in human cancersShijie Wu, Yiwen Wu, Sijun Deng, et al.
Discover Oncology|July 11, 2023
A pan-cancer analysis for the oncogenic role of cyclin-dependent kinase inhibitor 1B in human cancersHao Huang, Duoliang Qiu, Zhengyang Zhou, et al.
Pageof 423